Relation Therapeutics
Relation delivers a radically different approach that can better understand the biology of disease and rationally discover new therapeutics.
Relation Therapeutics has raised €56M across 2 funding rounds from 13 investors, most recently a Seed round in Mar 2024. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.relationrx.com ↗
Total raised
€56M
€55,767,633
Funding rounds
2
Investors
13
distinct backers
Active since
2022-06
latest 2024-03
Funding by year
EUR raised per yearRelation Therapeutics — funding by year — interactive chart.
Data table
| Relation Therapeutics — funding by year | |
|---|---|
| 2022 | €24M |
| 2024 | €32M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-15 | Seed | €32M | ARK Invest,DCVC,Deerfield,Jonathan Milner,Khosla Ventures,Magnetic Ventures+1 more | View deal → |
| 2022-06-10 | Seed | €24M | Capital,DCVC Bio,Jonathan Milner,Khosla Ventures,Magnetic Ventures,Mark Stevenson+2 more | View deal → |